- Home
- Publications
- Publication Search
- Publication Details
Title
Apolipoproteins in vascular biology and atherosclerotic disease
Authors
Keywords
-
Journal
Nature Reviews Cardiology
Volume 19, Issue 3, Pages 168-179
Publisher
Springer Science and Business Media LLC
Online
2021-10-10
DOI
10.1038/s41569-021-00613-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipoprotein(a) is robustly associated with aortic valve calcium
- (2021) Yannick Kaiser et al. HEART
- High-density lipoproteins, reverse cholesterol transport and atherogenesis
- (2021) Henry J. Pownall et al. Nature Reviews Cardiology
- Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2021) Ioanna Gouni-Berthold et al. Lancet Diabetes & Endocrinology
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
- (2020) Jan Borén et al. EUROPEAN HEART JOURNAL
- Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
- (2020) Tosha Williams et al. Molecular Neurodegeneration
- Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care
- (2020) Gerald F. Watts et al. Nature Reviews Cardiology
- Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
- (2020) Sotirios Tsimikas et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dual apolipoprotein C-II mimetic–apolipoprotein C-III antagonist peptide lowers plasma triglycerides
- (2020) Anna Wolska et al. Science Translational Medicine
- Antisense lipoprotein[a] therapy: State-of-the-art and future perspectives
- (2020) Giuseppe Lippi et al. European Journal of Internal Medicine
- Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk
- (2020) Anurag Mehta et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein(a) and calcific aortic valve stenosis: A systematic review
- (2020) Raviteja R. Guddeti et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
- (2020) C. Michael Gibson et al. AMERICAN HEART JOURNAL
- Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease
- (2019) Michael B. Boffa et al. Nature Reviews Cardiology
- Relationship Between Low‐Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab
- (2019) Michael D. Shapiro et al. Journal of the American Heart Association
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
- (2019) Marja-Riitta Taskinen et al. Current Atherosclerosis Reports
- Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
- (2019) Kang H. Zheng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vascular smooth muscle cells in atherosclerosis
- (2019) Gemma L. Basatemur et al. Nature Reviews Cardiology
- Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
- (2019) Yu Yamazaki et al. Nature Reviews Neurology
- Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
- (2019) Joseph L. Witztum et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond
- (2019) Elena V. Fuior et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Apolipoprotein B Particles and Cardiovascular Disease
- (2019) Allan D. Sniderman et al. JAMA Cardiology
- SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux
- (2018) Wen-Jun Shen et al. Annual Review of Physiology
- Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial
- (2018) Stephen J. Nicholls et al. JAMA Cardiology
- Monocyte-Macrophages and T Cells in Atherosclerosis
- (2017) Ira Tabas et al. IMMUNITY
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
- (2017) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms
- (2017) Salome Mack et al. JOURNAL OF LIPID RESEARCH
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Familial dysbetalipoproteinemia
- (2017) Charlotte Koopal et al. Current Opinion in Endocrinology Diabetes and Obesity
- The arterial microenvironment: the where and why of atherosclerosis
- (2016) A. Yurdagul et al. BIOCHEMICAL JOURNAL
- Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial InfarctionClinical Perspective
- (2016) C. Michael Gibson et al. CIRCULATION
- Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases
- (2016) Robert W. Mahley CLINICAL CHEMISTRY
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- Familial defective apolipoprotein B-100: A review
- (2016) Lars H. Andersen et al. Journal of Clinical Lipidology
- Mobility of “HSPG-bound” LPL explains how LPL is able to reach GPIHBP1 on capillaries
- (2016) Christopher M. Allan et al. JOURNAL OF LIPID RESEARCH
- Structure, function, and genetics of lipoprotein (a)
- (2016) Konrad Schmidt et al. JOURNAL OF LIPID RESEARCH
- Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification
- (2016) John T. Wilkins et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
- (2016) Jeffrey L. Cummings et al. Alzheimers Research & Therapy
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- A Pressure-dependent Model for the Regulation of Lipoprotein Lipase by Apolipoprotein C-II
- (2015) Nathan L. Meyers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
- (2015) Sotirios Tsimikas et al. LANCET
- Chylomicronaemia—current diagnosis and future therapies
- (2015) Amanda J. Brahm et al. Nature Reviews Endocrinology
- Apolipoprotein C-III: From Pathophysiology to Pharmacology
- (2015) Giuseppe Danilo Norata et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C
- (2015) Michael J Pencina et al. European Journal of Preventive Cardiology
- The GPIHBP1–LPL Complex Is Responsible for the Margination of Triglyceride-Rich Lipoproteins in Capillaries
- (2014) Chris N. Goulbourne et al. Cell Metabolism
- Molecular Mechanisms of Cellular Cholesterol Efflux
- (2014) Michael C. Phillips JOURNAL OF BIOLOGICAL CHEMISTRY
- Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
- (2014) Peter Willeit et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- HDL and cardiovascular disease
- (2014) Daniel J Rader et al. LANCET
- Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases
- (2014) Yadong Huang et al. NEUROBIOLOGY OF DISEASE
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Angiopoietin-Like Proteins: A Comprehensive Look
- (2014) Gaetano Santulli Frontiers in Endocrinology
- Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events
- (2013) Samia Mora et al. CIRCULATION
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk
- (2013) Gregory S. Thomas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study
- (2012) Allan D. Sniderman et al. ATHEROSCLEROSIS
- Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
- (2012) Evan A. Stein et al. CIRCULATION
- Mutations inLPL,APOC2,APOA5,GPIHBP1andLMF1in patients with severe hypertriglyceridaemia
- (2012) R. P. Surendran et al. JOURNAL OF INTERNAL MEDICINE
- Apolipoprotein A-V; a potent triglyceride reducer
- (2011) Stefan K. Nilsson et al. ATHEROSCLEROSIS
- Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants
- (2011) Kim G. Jackson et al. ATHEROSCLEROSIS
- Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT
- (2011) Ian Tietjen et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Lipase maturation factor 1: A lipase chaperone involved in lipid metabolism
- (2011) Miklós Péterfy BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects
- (2011) Salim S. Virani et al. CIRCULATION
- Apolipoproteins: metabolic role and clinical biochemistry applications
- (2011) M. H. Dominiczak et al. ANNALS OF CLINICAL BIOCHEMISTRY
- GPIHBP1 Is Responsible for the Entry of Lipoprotein Lipase into Capillaries
- (2010) Brandon S.J. Davies et al. Cell Metabolism
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
- Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
- (2010) Allan Sniderman et al. Nature Reviews Endocrinology
- The LDL Receptor
- (2009) Joseph L. Goldstein et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians
- (2009) Matthew B. Lanktree et al. Circulation-Cardiovascular Genetics
- ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
- (2009) A. Hiukka et al. DIABETES
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Structural and functional consequences of the Milano mutation (R173C) in human apolipoprotein A-I
- (2009) Eric T. Alexander et al. JOURNAL OF LIPID RESEARCH
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
- (2008) Matthew J McQueen et al. LANCET
- Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality control
- (2008) M. Pan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias
- (2008) Jacqueline de Graaf et al. Nature clinical practice. Endocrinology & metabolism
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More